✦ LIBER ✦

Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada

✍ Scribed by Lindsay Hedden; Hagen Kennecke; Diego Villa; Karrisa Johnston; Caroline Speers; Laurel Kovacic; Daniel J. Renouf; Stuart Peacock

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cost-effectiveness of bevacizumab in

✍ P. Tappenden; R. Jones; S. Paisley; C. Carroll 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Out-of-pocket payment and cost-effective

✍ Takeru Shiroiwa; Takashi Fukuda; Kiichiro Tsutani 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 595 KB

PCN95 COST-EFFECTIVENESS OF BEVACIZUMAB

✍ JH Kim; EK Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN26 A COST-EFFECTIVENESS ANALYSIS OF X

✍ J Darba; G Restovic; A Ramírez de Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN70 Cost-Effectiveness of Cetuximab an

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

3617 POSTER Cost-Effectiveness of Cetuxi

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB